Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› BRCA Mutation
Clinical trial register · Italy

BRCA Mutation Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6812 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
6812
Studies in scope
all four open statuses
4098
Recruiting now
open to new participants
1015
Lead sponsors
across recruiting studies
Top sites
Rome 2 Milan 2 Naples 2 Udine 1 Trento 1
Narrow the registerReset
Recruitment status
Phase
Site location
Rome2 Milan2 Naples2 Udine1 Trento1 Bari1 Catania1 Padova1 Roma1
All 9 locations
Target enrolment
to

BRCA Mutation trials in Italy

6 of 6812 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Robotic Nipple Sparing Mastectomy with Immediate Reconstruction
NCT06860217Breast Cancer, DCIS, BRCA Mutation
European Institute of Oncology
Not applicable
24
Milan
2025-04
Recruiting
Azienda Sanitaria-Universitaria Integrata di Udine
Not applicable
80
Udine
2025-01-08
Active, closed
A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial
NCT06497270BRCA Mutation, Estrogen Deficiency, Surgical Menopause, Menopause Related Conditions
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
3
Rome
2024-10-10
Recruiting
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517BRCA Mutation, Ovarian Cancer, Ultrasound Therapy; Complications
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
6,465
Rome
2023-03-20
Recruiting
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
NCT06783127Prostate Cancer, Castrate Resistant Prostate Cancer, BRCA Mutation
Santa Chiara Hospital
Observational
3,000
Naples, Trento
2023-01-01
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/brca-mutation

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,812 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies listing the condition BRCA Mutation.

How many BRCA Mutation trials are recruiting in Italy?

3 of the 6 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (BRCA Mutation), 6 studies
PhaseStudiesRecruitingShare
Not applicable3150%
Observational2233.3%
Phase 31016.7%

Most active sponsors

Lead sponsors with the most studies (BRCA Mutation)
Lead sponsorStudiesRecruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS21
AstraZeneca10
Azienda Sanitaria-Universitaria Integrata di Udine11
European Institute of Oncology10
Santa Chiara Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.